Recent Press Releases

Clinverse, Inc. Announces Strategic Partnership with eClinical Insights®

Fully Integrated Solution Delivers Unparalleled Visibility Across eClinical Ecosystem DURHAM, NC/CAMBRIDGE, MA — Clinverse, Inc., the new standard for automating the financial lifecycle of...

PolyTherics and Antitope form Abzena

New Company Created to be Leading Provider of Technologies and Services to Enable Better Biopharmaceuticals • PolyTherics and Antitope to continue to trade as wholly owned subsidiaries of Abzena...

Medidata and TransCelerate BioPharma Inc. Announce Joint Initiative

NEW YORK--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it is partnering with TransCelerate BioPharma Inc....

PAREXEL Launches Perceptive MyTrials® Data-Driven Monitoring To Increase Patient Safety And Reduce Clinical Trial Costs

BOSTON, May 20, 2014 -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced the launch of its Perceptive MyTrials® Data-Driven...

Covance Acquires Medaxial

Expanding global market access, reimbursement, and communications solutions PRINCETON, N.J., May 19, 2014 -- Covance, one of the world's largest and most comprehensive drug development services...

TKL Research Opens Research Clinic at the Fair Lawn Promenade

FAIR LAWN, N.J.--TKL Research, a full-service clinical research organization (CRO), is proud to announce the opening of its new research clinic in Fair Lawn, NJ. TKL's largest clinic to date,...

WuXi PharmaTech Completes Construction of New Biosafety Testing Facility in Suzhou

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today...

Bayer HealthCare extends access to clinical trial data

Bayer HealthCare joins internet portal "www.clinicalstudydatarequest.com" / Access to clinical trial data for qualified researchers fosters scientific innovation and development of...

PRA Adds Large Molecule Capabilities to U.S. Laboratory

Immunochemistry Services Now Available in Kansas RALEIGH, N.C. and LENEXA, Kansas – PRA, a leading clinical research organization, today announced that in addition to offering full-service...

Evotec AG reports results of first quarter 2014

- CONTINUING TO ACCELERATE INNOVATION EFFICIENCY STRATEGY IN NEWLY SEGMENTED BUSINESS FORMATION Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today reported...

WuXi PharmaTech Announces First-Quarter 2014 Results

SHANGHAI, May 14, 2014 -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development services company serving the pharmaceutical, biotechnology, and medical device industries, with...

Quintiles Announces Agreement to Acquire Encore Health Resources

Acquisition Will Bolster Quintiles' Expertise in Health-Information Analytics Services and Create Foundation for Expanded Services Suite RESEARCH TRIANGLE PARK, N.C. – May 12, 2014 –...

Evotec and Eternygen enter collaboration to identify and develop novel metabolic disease therapy

Berlin and Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and Eternygen GmbH, a privately owned biopharmaceutical company, today announced a drug discovery...

ICON Completes Acquisition of Aptiv Solutions

DUBLIN--ICON plc, (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has completed the...

WuXi PharmaTech Begins Construction of New R&D and cGMP Manufacturing Campus in Changzhou

SHANGHAI, May 8, 2014 -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development (R&D) services company with operations in...

WuXi PharmaTech Completes Construction of New Materials Characterization Facility in St. Paul

SHANGHAI, May 12, 2014 -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United...

Tigermed and Frontage Laboratories Announce Strategic Investment to Strengthen Global Drug Development Service Capabilities

EXTON, Pa.--Hangzhou Tigermed Consulting Co., Ltd. (hereafter 'Tigermed'), a leading provider of outsourced clinical development services across China and Asia Pacific to the pharmaceutical...

ONYX COMPLETES API PROJECT WITH US DRUG DEVELOPER

UK-based contract research organisation Onyx Scientific has completed a development and API manufacturing project with US-based Neuronascent, Inc to support the company with its focus on neurologic...

AMRI Announces First Quarter 2014 Results

Contract Revenue Growth of 10% to $51.0 Million and Adjusted Diluted EPS of $0.16 Company Increases 2014 Adjusted EPS Guidance to $0.78 - $0.84 to Reflect Addition of Cedarburg Pharmaceuticals and...

Cytovance Biologics, Inc. and Selexys Pharmaceuticals, Corp. Announce Development and cGMP Manufacturing Agreement for SELK2 Drug Product

Cytovance Biologics, Inc. and Selexys Pharmaceuticals, Corp. Announce Development and cGMP Manufacturing Agreement for SELK2 Drug Product Oklahoma City, OK (May 6, 2014)-- Cytovance Biologics, Inc.,...